drugset / Trial / NCT04298853

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

NCT04298853

Phase 4 Completed 17 enrolled Indiana University
RandomizedParallel-groupOpen-labelOther

Summary

Randomized pilot trial comparing scheduled morphine dosing with a weaning protocol to intermittent morphine dosing on an as-needed basis for newborns with neonatal abstinence syndrome.

Timeline

Start
2020-06-30
Primary completion
2021-10-01
Completion
2021-10-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 0.05 mg/kg Oral